M&A Deal Summary |
|
|---|---|
| Date | 2011-02-14 |
| Target | Chemagen Biopolymer-Technologie AG |
| Sector | Life Science |
| Buyer(s) | Revvity |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Mummert & Company Corporate Finance GmbH (Financial) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1937 |
| Sector | Medical Products |
| Employees | 11,000 |
| Revenue | 2.8B USD (2024) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 37 |
| Sector: Life Science M&A | 3 of 8 |
| Type: Add-on Acquisition M&A Deals | 15 of 35 |
| Country: Germany M&A | 2 of 4 |
| Year: 2011 M&A | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-29 |
Excelitas Technologies
Waltham, Massachusetts, United States Excelitas Technologies is a global provider of photonics technology solutions. The Company’s components, modules and sub-systems enable its customers to develop unique, technology-driven products that serve a broad range of growing end markets. Excelitas’ core capabilities include expertise in detection, optics, illumination and advanced electronics. The Company primarily targets high-growth applications within the life sciences, industrial, semiconductor, consumer and defense and aerospace markets. Excelitas Technologies was founded in 1931 and is based in Waltham, Massachusetts. |
Sell | $500M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-24 |
CambridgeSoft
Cambridge,, Massachusetts, United States CambridgeSoft Corporation provides software services to life science. |
Buy | - |
